Science in Sport plc

AIM:SIS Stock Report

Market Cap: UK£61.0m

Science in Sport Valuation

Is SIS undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of SIS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: SIS (£0.27) is trading above our estimate of fair value (£0.02)

Significantly Below Fair Value: SIS is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for SIS?

Key metric: As SIS is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for SIS. This is calculated by dividing SIS's market cap by their current revenue.
What is SIS's PS Ratio?
PS Ratio1.1x
SalesUK£53.94m
Market CapUK£61.01m

Price to Sales Ratio vs Peers

How does SIS's PS Ratio compare to its peers?

The above table shows the PS ratio for SIS vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average0.6x
REVB Revolution Beauty Group
0.2x-1.6%UK£40.2m
VLG Venture Life Group
1x9.6%UK£49.9m
CRL Creightons
0.4xn/aUK£23.7m
PZC PZ Cussons
0.6x1.2%UK£322.4m
SIS Science in Sport
1.1x8.9%UK£61.0m

Price-To-Sales vs Peers: SIS is expensive based on its Price-To-Sales Ratio (1.1x) compared to the peer average (0.6x).

Price to Sales Ratio vs Industry

How does SIS's PS Ratio compare vs other companies in the European Personal Products Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
SIS 1.1xIndustry Avg. 1.5xNo. of Companies10PS01.63.24.86.48+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: SIS is good value based on its Price-To-Sales Ratio (1.1x) compared to the European Personal Products industry average (1.5x).

Price to Sales Ratio vs Fair Ratio

What is SIS's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

SIS PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ratio0.8x

Price-To-Sales vs Fair Ratio: SIS is expensive based on its Price-To-Sales Ratio (1.1x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Gr. Sarantis

€677.7m

Produces and trades cosmetics, household, and parapharmaceutical products.

0IIO

€10.86

7D

0.2%

1Y

n/a

Ontex Group

€607.0m

Develops, produces, and supplies personal hygiene products and solutions for baby, feminine, and adult care in Belgium, the United Kingdom, the United States, Italy, France, and internationally.

0QVQ

€7.51

7D

1.8%

1Y

7.5%

McBride

UK£175.8m

Manufactures and sells private label household and personal care products to retailers and brand owners in the United Kingdom, Germany, France, Italy, Spain, rest of Europe, Asia-Pacific, and internationally.It operates through five segments: Liquids, Powders, Unit dosing, Aerosols, and Asia Pacific.

MCBL

UK£1.02

7D

2.0%

1Y

70.0%